Standards & methodology
A published methodology that brands, pharmacists, and consumers can review in full.
The framework defines the six weighted dimensions used in every product review: scientific evidence (25%), safety (20%), ingredient quality (20%), manufacturing quality (15%), label accuracy (10%), and pharmacist evaluation (10%). Weights are fixed across categories to ensure consistency.
Brands are asked to provide peer-reviewed clinical studies, mechanism-of-action data, and any regulatory documentation supporting the intended use. Preference is given to randomized controlled trials, systematic reviews, and studies aligned with the product's actual formulation and dose.
The methodology calls for relevant published evidence beyond the submitted dossier, including indexed literature such as PubMed and the Cochrane Library. Conflicting findings should be documented and considered. This describes the review policy, not proof of a completed review or audit.
Each active and functional ingredient is evaluated for identity, purity, sourcing transparency, and known interactions. Novel ingredients require additional documentation on safety and mechanism.
Labeling is reviewed for accuracy of claims, appropriate warnings, dosage clarity, and alignment with applicable regulatory guidance. Marketing language that overstates evidence is flagged.
Safety assessment covers contraindications, drug interactions, population-specific risks (pregnancy, pediatrics, geriatrics), and post-market adverse-event patterns where available.
Our team is available to walk brands, pharmacists, and researchers through the framework in detail.